Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.01 on Thursday. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.02. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.